LIXT
Lixte Biotechnology·NASDAQ
--
--(--)
--
--(--)
LIXT fundamentals
Lixte Biotechnology (LIXT) released its earnings on Aug 7, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.29 (YoY +35.56%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.29
+35.56%
Report date
Aug 7, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Lixte Biotechnology (LIXT) key financial stats and ratios, covering profitability, financial health, and leverage.
Lixte Biotechnology (LIXT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lixte Biotechnology (LIXT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lixte Biotechnology (LIXT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lixte Biotechnology (LIXT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lixte Biotechnology (LIXT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Lixte Biotechnology's management provide for the next earnings period?What were the key takeaways from Lixte Biotechnology's earnings call?What does Lixte Biotechnology do and what are its main business segments?What were the key takeaways from Lixte Biotechnology’s earnings call?Did Lixte Biotechnology beat or miss consensus estimates last quarter?What is the market's earnings forecast for Lixte Biotechnology next quarter?What factors drove the changes in Lixte Biotechnology's revenue and profit?What is Lixte Biotechnology's gross profit margin?
